Exchange: NASDAQ·Updated 11:43 AM EDT

About

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Clinuvel Pharmaceuticals Ltd - ADR?
What is the 52-week high for Clinuvel Pharmaceuticals Ltd - ADR?
What is the 52-week low for Clinuvel Pharmaceuticals Ltd - ADR?
What is Clinuvel Pharmaceuticals Ltd - ADR stock price today?
What was Clinuvel Pharmaceuticals Ltd - ADR stock price yesterday?
What is the PE ratio of Clinuvel Pharmaceuticals Ltd - ADR?
What is the Price-to-Book ratio of Clinuvel Pharmaceuticals Ltd - ADR?
What is the 50-day moving average of Clinuvel Pharmaceuticals Ltd - ADR?

Advertisement|Remove ads.